Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of blood biomarkers for psychosis using convergent functional genomics.

Molecular psychiatry - 1 Jan 2011

Kurian S M, Le-Niculescu H, Patel S D, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, Lohr J, Lahiri D K, Nurnberger J I, Faraone S V, Geyer M A, Tsuang M T, Schork N J, Salomon D R, Niculescu A B

Abstract excerpt

There are to date no objective clinical laboratory blood tests for psychotic disease states. We provide proof of principle for a convergent functional genomics (CFG) approach to help identify and prioritize blood biomarkers for two key psychotic symptoms, one sensory (hallucinations) and one cogn...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Delusions
Share to Gene Expression Profiling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation

Share to Genomics

Share to Hallucinations

Share to Psychotic Disorders

Share to Schizophrenia

Source

Identifiers

PMID: 19935739
DOI: 10.1038/mp.2009.117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19935739-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of blood biomarkers for psychosis using convergent functional genomics.PMID 19935739Read ↗

Gene expression over the course of schizophrenia: from clinical high-risk for psychosis to chronic stagesSemantic proximity Read ↗

Differential gene expression analysis in blood of first episode psychosis patientsSemantic proximity Read ↗

Identifying circulating protein targets for common factors underlying schizophrenia, depression, and bipolar disorderSemantic proximity Read ↗

Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals.Semantic proximity Read ↗

An Integrative Analysis Identified Schizophrenia-Associated Brain Cell Types and Gene Expression ChangesSemantic proximity Read ↗

Patients with schizophrenia and bipolar disorder display a similar global gene expression signature in whole blood that reflects elevated proportion of immature neutrophil cells with association to lipid changesSemantic proximity Read ↗

Shared gene expression alterations in schizophrenia and bipolar disorder.Semantic proximity Read ↗

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.Semantic proximity Read ↗

Gene expression overlap between neuropsychiatric disordersSemantic proximity Read ↗

Identification of a Hypoxia-Related Signature as Candidate Detector for Schizophrenia Based on Genome-Wide Gene Expression.Semantic proximity Read ↗

Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder.Semantic proximity Read ↗

Genome-wide expression analysis of peripheral blood identifies candidate biomarkers for schizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.